Leo Buckley, Pharm.D.

Sources

Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.

1. [1]

   Leo Buckley, Pharm.D. - Faculty Profile - UT Southwestern

   17 source claims · Reviewed Sep 7, 2026

   Show supporting evidence

   Biographical context: Buckley completed pharmacy training at Northeastern University, pharmacy-practice and cardiovascular-pharmacotherapy residencies at Brigham and Women's Hospital, and an experimental cardiovascular pharmacotherapy fellowship at Virginia Commonwealth University. He earned an M.P.H. in clinical effectiveness at Harvard and joined UT Southwestern in 2025 after serving as a clinical pharmacy specialist and investigator at Brigham and Women's Hospital.

   Biography Leo F. Buckley, PharmD, MPH, FAHA, FACC, is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. He provides evidence-based pharmacotherapy for patients with complex cardiomyopathies in the Cardiomyopathy and Heart Failure Clinic. Originally from Boston, he completed pharmacy school at Northeastern University, residency training in Pharmacy Practice and in Cardiovascular Pharmacotherapy at Brigham and Women's Hospital and an Experimental Cardiovascular Pharmacotherapy fellowship at Virginia Commonwealth University. He also holds a Master of Public Health with a concentration in clinical effectiveness from the Harvard T.H. Chan School of Public Health. Prior to joining the UT Southwestern faculty in 2025, he served as a Clinical Pharmacy Specialist and Clinical Investigator in the Department of Pharmacy at Brigham and Women's Hospital. As a cardiovascular pharmacotherapy researcher and clinician, he bridges molecular discovery with clinical implementation to improve heart failure prevention and treatment. His clinical research program integrates mechanistic clinical trials, epidemiology and advanced multi-omics (pharmaco-genomics/-proteomics/-metabolomics and single-cell analysis) to define how drugs modulate cardiac structure and function with the overall goal of developing novel, precision therapeutics for the prevention and treatment of heart failure. Current areas of emphasis include: defining the effects of iron repletion on cardiac structure, function, and energetics; elucidating molecular mechanisms of colchicine and anti-cytokine therapies; applying genomic, proteomic, metabolomic and single-cell analysis data to optimize cardiovascular drug interventions.

   Biographical context: His current work examines iron repletion, colchicine and anti-cytokine mechanisms, and the use of genomic, proteomic, metabolomic, and single-cell data to optimize cardiovascular drug interventions.

   Biography Leo F. Buckley, PharmD, MPH, FAHA, FACC, is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. He provides evidence-based pharmacotherapy for patients with complex cardiomyopathies in the Cardiomyopathy and Heart Failure Clinic. Originally from Boston, he completed pharmacy school at Northeastern University, residency training in Pharmacy Practice and in Cardiovascular Pharmacotherapy at Brigham and Women's Hospital and an Experimental Cardiovascular Pharmacotherapy fellowship at Virginia Commonwealth University. He also holds a Master of Public Health with a concentration in clinical effectiveness from the Harvard T.H. Chan School of Public Health. Prior to joining the UT Southwestern faculty in 2025, he served as a Clinical Pharmacy Specialist and Clinical Investigator in the Department of Pharmacy at Brigham and Women's Hospital. As a cardiovascular pharmacotherapy researcher and clinician, he bridges molecular discovery with clinical implementation to improve heart failure prevention and treatment. His clinical research program integrates mechanistic clinical trials, epidemiology and advanced multi-omics (pharmaco-genomics/-proteomics/-metabolomics and single-cell analysis) to define how drugs modulate cardiac structure and function with the overall goal of developing novel, precision therapeutics for the prevention and treatment of heart failure. Current areas of emphasis include: defining the effects of iron repletion on cardiac structure, function, and energetics; elucidating molecular mechanisms of colchicine and anti-cytokine therapies; applying genomic, proteomic, metabolomic and single-cell analysis data to optimize cardiovascular drug interventions.

   Biographical context: Leo Buckley provides evidence-based pharmacotherapy for complex cardiomyopathies in the Cardiomyopathy and Heart Failure Clinic. His research combines mechanistic trials, epidemiology, and multi-omics to study precision drug strategies for heart failure prevention and treatment.

   Biography Leo F. Buckley, PharmD, MPH, FAHA, FACC, is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. He provides evidence-based pharmacotherapy for patients with complex cardiomyopathies in the Cardiomyopathy and Heart Failure Clinic. Originally from Boston, he completed pharmacy school at Northeastern University, residency training in Pharmacy Practice and in Cardiovascular Pharmacotherapy at Brigham and Women's Hospital and an Experimental Cardiovascular Pharmacotherapy fellowship at Virginia Commonwealth University. He also holds a Master of Public Health with a concentration in clinical effectiveness from the Harvard T.H. Chan School of Public Health. Prior to joining the UT Southwestern faculty in 2025, he served as a Clinical Pharmacy Specialist and Clinical Investigator in the Department of Pharmacy at Brigham and Women's Hospital. As a cardiovascular pharmacotherapy researcher and clinician, he bridges molecular discovery with clinical implementation to improve heart failure prevention and treatment. His clinical research program integrates mechanistic clinical trials, epidemiology and advanced multi-omics (pharmaco-genomics/-proteomics/-metabolomics and single-cell analysis) to define how drugs modulate cardiac structure and function with the overall goal of developing novel, precision therapeutics for the prevention and treatment of heart failure. Current areas of emphasis include: defining the effects of iron repletion on cardiac structure, function, and energetics; elucidating molecular mechanisms of colchicine and anti-cytokine therapies; applying genomic, proteomic, metabolomic and single-cell analysis data to optimize cardiovascular drug interventions.

   Education record: Northeastern University (Pharmacy school)

   Originally from Boston, he completed pharmacy school at Northeastern University, residency training in Pharmacy Practice and in Cardiovascular Pharmacotherapy at Brigham and Women's Hospital and an Experimental Cardiovascular Pharmacotherapy fellowship at Virginia Commonwealth University. He also holds a Master of Public Health with a concentration in clinical effectiveness from the Harvard T.H. Chan School of Public Health.

   Fellowship: Virginia Commonwealth University (Experimental Cardiovascular Pharmacotherapy)

   Originally from Boston, he completed pharmacy school at Northeastern University, residency training in Pharmacy Practice and in Cardiovascular Pharmacotherapy at Brigham and Women's Hospital and an Experimental Cardiovascular Pharmacotherapy fellowship at Virginia Commonwealth University. He also holds a Master of Public Health with a concentration in clinical effectiveness from the Harvard T.H. Chan School of Public Health.

   Graduate education: Harvard T.H. Chan School of Public Health (Master of Public Health, clinical effectiveness)

   Originally from Boston, he completed pharmacy school at Northeastern University, residency training in Pharmacy Practice and in Cardiovascular Pharmacotherapy at Brigham and Women's Hospital and an Experimental Cardiovascular Pharmacotherapy fellowship at Virginia Commonwealth University. He also holds a Master of Public Health with a concentration in clinical effectiveness from the Harvard T.H. Chan School of Public Health.

   Official headshot: Portrait

   <img src="https://profileplus.swmed.edu/facultydata/223842/images/buckley-leo-inset.jpg" class="card__image" itemprop="image" alt="Leo Buckley, Pharm.D. " style="max-width:200px;" />

   Official profile: Official profile

   Biography Leo F. Buckley, PharmD, MPH, FAHA, FACC, is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. He provides evidence-based pharmacotherapy for patients with complex cardiomyopathies in the Cardiomyopathy and Heart Failure Clinic. Originally from Boston, he completed pharmacy school at Northeastern University, residency training in Pharmacy Practice and in Cardiovascular Pharmacotherapy at Brigham and Women's Hospital and an Experimental Cardiovascular Pharmacotherapy fellowship at Virginia Commonwealth University. He also holds a Master of Public Health with a concentration in clinical effectiveness from the Harvard T.H. Chan School of Public Health. Prior to joining the UT Southwestern faculty in 2025, he served as a Clinical Pharmacy Specialist and Clinical Investigator in the Department of Pharmacy at Brigham and Women's Hospital. As a cardiovascular pharmacotherapy researcher and clinician, he bridges molecular discovery with clinical implementation to improve heart failure prevention and treatment. His clinical research program integrates mechanistic clinical trials, epidemiology and advanced multi-omics (pharmaco-genomics/-proteomics/-metabolomics and single-cell analysis) to define how drugs modulate cardiac structure and function with the overall goal of developing novel, precision therapeutics for the prevention and treatment of heart failure. Current areas of emphasis include: defining the effects of iron repletion on cardiac structure, function, and energetics; elucidating molecular mechanisms of colchicine and anti-cytokine therapies; applying genomic, proteomic, metabolomic and single-cell analysis data to optimize cardiovascular drug interventions.

   Research interests: colchicine

   Biography Leo F. Buckley, PharmD, MPH, FAHA, FACC, is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. He provides evidence-based pharmacotherapy for patients with complex cardiomyopathies in the Cardiomyopathy and Heart Failure Clinic. Originally from Boston, he completed pharmacy school at Northeastern University, residency training in Pharmacy Practice and in Cardiovascular Pharmacotherapy at Brigham and Women's Hospital and an Experimental Cardiovascular Pharmacotherapy fellowship at Virginia Commonwealth University. He also holds a Master of Public Health with a concentration in clinical effectiveness from the Harvard T.H. Chan School of Public Health. Prior to joining the UT Southwestern faculty in 2025, he served as a Clinical Pharmacy Specialist and Clinical Investigator in the Department of Pharmacy at Brigham and Women's Hospital. As a cardiovascular pharmacotherapy researcher and clinician, he bridges molecular discovery with clinical implementation to improve heart failure prevention and treatment. His clinical research program integrates mechanistic clinical trials, epidemiology and advanced multi-omics (pharmaco-genomics/-proteomics/-metabolomics and single-cell analysis) to define how drugs modulate cardiac structure and function with the overall goal of developing novel, precision therapeutics for the prevention and treatment of heart failure. Current areas of emphasis include: defining the effects of iron repletion on cardiac structure, function, and energetics; elucidating molecular mechanisms of colchicine and anti-cytokine therapies; applying genomic, proteomic, metabolomic and single-cell analysis data to optimize cardiovascular drug interventions.

   Research interests: epidemiology

   Biography Leo F. Buckley, PharmD, MPH, FAHA, FACC, is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. He provides evidence-based pharmacotherapy for patients with complex cardiomyopathies in the Cardiomyopathy and Heart Failure Clinic. Originally from Boston, he completed pharmacy school at Northeastern University, residency training in Pharmacy Practice and in Cardiovascular Pharmacotherapy at Brigham and Women's Hospital and an Experimental Cardiovascular Pharmacotherapy fellowship at Virginia Commonwealth University. He also holds a Master of Public Health with a concentration in clinical effectiveness from the Harvard T.H. Chan School of Public Health. Prior to joining the UT Southwestern faculty in 2025, he served as a Clinical Pharmacy Specialist and Clinical Investigator in the Department of Pharmacy at Brigham and Women's Hospital. As a cardiovascular pharmacotherapy researcher and clinician, he bridges molecular discovery with clinical implementation to improve heart failure prevention and treatment. His clinical research program integrates mechanistic clinical trials, epidemiology and advanced multi-omics (pharmaco-genomics/-proteomics/-metabolomics and single-cell analysis) to define how drugs modulate cardiac structure and function with the overall goal of developing novel, precision therapeutics for the prevention and treatment of heart failure. Current areas of emphasis include: defining the effects of iron repletion on cardiac structure, function, and energetics; elucidating molecular mechanisms of colchicine and anti-cytokine therapies; applying genomic, proteomic, metabolomic and single-cell analysis data to optimize cardiovascular drug interventions.

   Research interests: heart failure pharmacotherapy

   Biography Leo F. Buckley, PharmD, MPH, FAHA, FACC, is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. He provides evidence-based pharmacotherapy for patients with complex cardiomyopathies in the Cardiomyopathy and Heart Failure Clinic. Originally from Boston, he completed pharmacy school at Northeastern University, residency training in Pharmacy Practice and in Cardiovascular Pharmacotherapy at Brigham and Women's Hospital and an Experimental Cardiovascular Pharmacotherapy fellowship at Virginia Commonwealth University. He also holds a Master of Public Health with a concentration in clinical effectiveness from the Harvard T.H. Chan School of Public Health. Prior to joining the UT Southwestern faculty in 2025, he served as a Clinical Pharmacy Specialist and Clinical Investigator in the Department of Pharmacy at Brigham and Women's Hospital. As a cardiovascular pharmacotherapy researcher and clinician, he bridges molecular discovery with clinical implementation to improve heart failure prevention and treatment. His clinical research program integrates mechanistic clinical trials, epidemiology and advanced multi-omics (pharmaco-genomics/-proteomics/-metabolomics and single-cell analysis) to define how drugs modulate cardiac structure and function with the overall goal of developing novel, precision therapeutics for the prevention and treatment of heart failure. Current areas of emphasis include: defining the effects of iron repletion on cardiac structure, function, and energetics; elucidating molecular mechanisms of colchicine and anti-cytokine therapies; applying genomic, proteomic, metabolomic and single-cell analysis data to optimize cardiovascular drug interventions.

   Research interests: inflammation

   Research Interest Colchicine Epidemiology Genomics Inflammation Iron Deficiency Metabolomics Pharmacogenomics Proteomics Single-Cell Analysis

   Research interests: iron deficiency

   Research Interest Colchicine Epidemiology Genomics Inflammation Iron Deficiency Metabolomics Pharmacogenomics Proteomics Single-Cell Analysis

   Research interests: metabolomics

   Biography Leo F. Buckley, PharmD, MPH, FAHA, FACC, is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. He provides evidence-based pharmacotherapy for patients with complex cardiomyopathies in the Cardiomyopathy and Heart Failure Clinic. Originally from Boston, he completed pharmacy school at Northeastern University, residency training in Pharmacy Practice and in Cardiovascular Pharmacotherapy at Brigham and Women's Hospital and an Experimental Cardiovascular Pharmacotherapy fellowship at Virginia Commonwealth University. He also holds a Master of Public Health with a concentration in clinical effectiveness from the Harvard T.H. Chan School of Public Health. Prior to joining the UT Southwestern faculty in 2025, he served as a Clinical Pharmacy Specialist and Clinical Investigator in the Department of Pharmacy at Brigham and Women's Hospital. As a cardiovascular pharmacotherapy researcher and clinician, he bridges molecular discovery with clinical implementation to improve heart failure prevention and treatment. His clinical research program integrates mechanistic clinical trials, epidemiology and advanced multi-omics (pharmaco-genomics/-proteomics/-metabolomics and single-cell analysis) to define how drugs modulate cardiac structure and function with the overall goal of developing novel, precision therapeutics for the prevention and treatment of heart failure. Current areas of emphasis include: defining the effects of iron repletion on cardiac structure, function, and energetics; elucidating molecular mechanisms of colchicine and anti-cytokine therapies; applying genomic, proteomic, metabolomic and single-cell analysis data to optimize cardiovascular drug interventions.

   Research interests: pharmacogenomics

   Research Interest Colchicine Epidemiology Genomics Inflammation Iron Deficiency Metabolomics Pharmacogenomics Proteomics Single-Cell Analysis

   Research interests: proteomics

   Biography Leo F. Buckley, PharmD, MPH, FAHA, FACC, is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. He provides evidence-based pharmacotherapy for patients with complex cardiomyopathies in the Cardiomyopathy and Heart Failure Clinic. Originally from Boston, he completed pharmacy school at Northeastern University, residency training in Pharmacy Practice and in Cardiovascular Pharmacotherapy at Brigham and Women's Hospital and an Experimental Cardiovascular Pharmacotherapy fellowship at Virginia Commonwealth University. He also holds a Master of Public Health with a concentration in clinical effectiveness from the Harvard T.H. Chan School of Public Health. Prior to joining the UT Southwestern faculty in 2025, he served as a Clinical Pharmacy Specialist and Clinical Investigator in the Department of Pharmacy at Brigham and Women's Hospital. As a cardiovascular pharmacotherapy researcher and clinician, he bridges molecular discovery with clinical implementation to improve heart failure prevention and treatment. His clinical research program integrates mechanistic clinical trials, epidemiology and advanced multi-omics (pharmaco-genomics/-proteomics/-metabolomics and single-cell analysis) to define how drugs modulate cardiac structure and function with the overall goal of developing novel, precision therapeutics for the prevention and treatment of heart failure. Current areas of emphasis include: defining the effects of iron repletion on cardiac structure, function, and energetics; elucidating molecular mechanisms of colchicine and anti-cytokine therapies; applying genomic, proteomic, metabolomic and single-cell analysis data to optimize cardiovascular drug interventions.

   Residency: Brigham and Women's Hospital (Pharmacy Practice and Cardiovascular Pharmacotherapy)

   Originally from Boston, he completed pharmacy school at Northeastern University, residency training in Pharmacy Practice and in Cardiovascular Pharmacotherapy at Brigham and Women's Hospital and an Experimental Cardiovascular Pharmacotherapy fellowship at Virginia Commonwealth University. He also holds a Master of Public Health with a concentration in clinical effectiveness from the Harvard T.H. Chan School of Public Health.

2. [2]

   UT Southwestern Division of Cardiology faculty directory

   1 source claim · Reviewed Sep 7, 2026

   Show supporting evidence

   Professional role: Assistant Professor

   Leo Buckley, Pharm.D. Assistant Professor Cardiovascular Pharmacotherapy Research